Hyperactivity News and Research

RSS

TBI: Increased levels of immune cells promote inflammation that may worsen brain damage

Immediately after a traumatic brain injury and as long as one year later, there are increased levels of immune cells called ILCs in the brain promoting inflammation, which can worsen brain damage, scientists report.

27 Jan 2021

Anchor proteins inhibit a key metabolic driver involved in cancer and neuronal diseases

Certain anchor proteins inhibit a key metabolic driver that plays an important role in cancer and developmental brain disorders.

27 Jan 2021

Microglia surveillance helps prevent seizure activity in the brain

An important part of the brain's immune system, cells called microglia constantly extend and retract "branches" from their cell body to survey their environment.

15 Dec 2020

Study suggests that melatonin may be a viable treatment option for COVID-19

New findings indicate that melatonin could be a potential treatment option for COVID-19.

10 Nov 2020

ADHD study reveals genetic differences between African Americans and people of European ancestry

Researchers from Children's Hospital of Philadelphia (CHOP) have shown there may be key genetic differences in the causes of attention-deficit hyperactivity disorder (ADHD) between African Americans and people of European ancestry, which may play an important part in how patients of different ethnic backgrounds respond to treatments for this condition. The findings were published online by the journal Scientific Reports.

23 Sep 2020

Combining stem cell therapy with educational intervention can help children with autism

Results of a clinical trial released today in STEM CELLS Translational Medicine indicate that a combination of stem cell therapy and educational intervention can significantly help children with autism spectrum disorder (ASD).

10 Sep 2020

Researchers identify brain protein that leads to seizures, abnormal social behaviors

Scientists have identified a novel mechanism that is responsible for causing the abnormal development of neuronal connections in the mice brain.

1 Sep 2020

COVID-19 makes platelets 'hyperactive' and more prone to form deadly blood clots

Changes in blood platelets triggered by COVID-19 could contribute to the onset of heart attacks, strokes, and other serious complications in some patients who have the disease, according to University of Utah Health scientists.

2 Jul 2020

Synthetic molecule suppresses drug cravings with fewer side effects

A new synthetic molecule selectively reduces the physiological rewards of cocaine in mice.

1 Jun 2020

ADHD-associated genetic variants have reduced progressively in human lineage

According to a study published in the Scientific Reports journal, the frequency of genetic variants linked to attention-deficit/hyperactivity disorder (ADHD) has reduced progressively in the evolutionary human lineage from the Palaeolithic to the present day.

29 May 2020

Hyperactivity News and Research

TBI: Increased levels of immune cells promote inflammation that may worsen brain damage

Anchor proteins inhibit a key metabolic driver involved in cancer and neuronal diseases

Microglia surveillance helps prevent seizure activity in the brain

Study suggests that melatonin may be a viable treatment option for COVID-19

ADHD study reveals genetic differences between African Americans and people of European ancestry

Combining stem cell therapy with educational intervention can help children with autism

Researchers identify brain protein that leads to seizures, abnormal social behaviors

COVID-19 makes platelets 'hyperactive' and more prone to form deadly blood clots

Synthetic molecule suppresses drug cravings with fewer side effects

ADHD-associated genetic variants have reduced progressively in human lineage

Lipid metabolism enzyme regulates brain stem cell activity

Antibodies Could Provide New Treatment For OCD

Study unveils genetic variants that play key role in psychiatric, neurological conditions

New canine study can benefit diagnostics and treatment of retinitis pigmentosa

Distinct loss-of-function variants cause shared clinical features in neuronal development disorders

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics